# Quantitative Proteomic Analysis Indicates That Pggt1b Deficiency Promotes Cytokine Secretion in Resiquimod‐Stimulated Bone Marrow‐Derived Macrophages via the NF‐κB Pathway

**Authors:** Shanshan Yu, Xuecui Wei, Fangyuan Long, Heng Gu, Zhimin Hao

PMC · DOI: 10.1002/iid3.70185 · Immunity, Inflammation and Disease · 2025-04-07

## TL;DR

This study shows that reduced PGGT1B in macrophages increases inflammation via the NF-κB pathway, which may contribute to psoriasis.

## Contribution

The study reveals a novel role of Pggt1b in regulating cytokine secretion through the NF-κB pathway in psoriasis-related macrophages.

## Key findings

- Pggt1b deficiency increases cytokine production in R848-stimulated macrophages.
- Six hub proteins were identified as key in Pggt1b-mediated inflammation.
- Pggt1b regulates inflammation via the NF-κB pathway in macrophages.

## Abstract

Psoriasis is a systemic inflammatory skin disease mediated by the innate and adaptive immune systems. Recent studies have indicated that macrophages may contribute to the pathogenesis of psoriasis. However, the role of macrophage protein geranylgeranyl transferase type‐1β subunit (PGGT1B) in psoriasis is unclear. In this study, we aimed to establish how a reduction in Pggt1b expression in monocytes influences the onset and progression of psoriasis.

Myeloid cell‐specific Pggt1b knockout mice were generated, and their bone marrow‐derived macrophages (BMDMs) were stimulated with resiquimod (R848) to mimic the psoriatic immune microenvironment. The proteomic analysis enabled us to identify 17 differentially expressed proteins associated with Pggt1b deficiency in the psoriasis macrophage model (folded change ≥ 1.3 and p < 0.05). Gene Ontology and Kyoto Encyclopedia of Genes and Genomes enrichment was performed. Quantitative reverse transcription‐polymerase chain reaction (qRT‐PCR) and western blot assays were used to verify the differentially expressed proteins and signaling pathways. Finally, an enzyme‐linked immunosorbent assay was used to verify the expression of the key inflammatory cytokine interleukin (IL)‐1β.

In total, six proteins (Dlgap5, Fas, Fnta, Nlrp3, Cd14, and Ticam2) were identified as hub proteins. Furthermore, we found that Pggt1b might mediate R848‐induced inflammation via the small G‐proteins Rac1 or Cdc42. We found that Pggt1b positively regulates pro‐inflammatory responses in R848‐stimulated BMDMs via the NF‐κB signaling pathway.

This study clarified that PGGT1B affected the synthesis of inflammatory cytokines via NF‐κB pathway and provided insights into the mechanisms underlying immune responses and inflammation.

In Pggt1b‐deficient macrophages, TLR4 may be in a highly activated state and can be activated by R848 or DAMPS, which strongly correlated with increased cytokine production, interferon‐γ production, augmented amide binding and transferase activity, and the activation of NF‐κB and/or Nlrp3 inflammasome pathways.

## Linked entities

- **Genes:** PGGT1B (protein geranylgeranyltransferase type I subunit beta) [NCBI Gene 5229], DLGAP5 (DLG associated protein 5) [NCBI Gene 9787], FAS (Fas cell surface death receptor) [NCBI Gene 355], FNTA (farnesyltransferase, CAAX box, subunit alpha) [NCBI Gene 2339], NLRP3 (NLR family pyrin domain containing 3) [NCBI Gene 114548], CD14 (CD14 molecule) [NCBI Gene 929], TICAM2 (TIR domain containing adaptor molecule 2) [NCBI Gene 353376]
- **Proteins:** PGGT1B (protein geranylgeranyltransferase type I subunit beta), RAC1 (Rac family small GTPase 1), CDC42 (cell division cycle 42), TLR4 (toll like receptor 4), NLRP3 (NLR family pyrin domain containing 3), NFKB1 (nuclear factor kappa B subunit 1)
- **Chemicals:** resiquimod (PubChem CID 159603), R848 (PubChem CID 159603)
- **Diseases:** psoriasis (MONDO:0005083)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Dlgap5 (DLG associated protein 5) [NCBI Gene 218977] {aka Dap-5, Dlg7, Hurp, mKIAA0008}, Pggt1b (protein geranylgeranyltransferase type I, beta subunit) [NCBI Gene 225467] {aka 2010207C17Rik, 2610100E13, BGG1, GGT1}, Cdc42 (cell division cycle 42) [NCBI Gene 12540], Nlrp3 (NLR family, pyrin domain containing 3) [NCBI Gene 216799] {aka AGTAVPRL, AII/AVP, Cias1, FCAS, FCU, MWS}, Ticam2 (TIR domain containing adaptor molecule 2) [NCBI Gene 225471] {aka B430113A10, TICAM-2, TRAM, Tirp, Trif}, Rac1 (Rac family small GTPase 1) [NCBI Gene 19353] {aka D5Ertd559e}, Nfkb1 (nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105) [NCBI Gene 18033] {aka NF-KB1, NF-kappaB, NF-kappaB1, p105, p50, p50/p105}, Fnta (farnesyltransferase, CAAX box, alpha) [NCBI Gene 14272] {aka FTA}, Cd14 (CD14 antigen) [NCBI Gene 12475]
- **Diseases:** inflammation (MESH:D007249), psoriatic (MESH:D015535), Psoriasis (MESH:D011565), inflammatory skin disease (MESH:D012871)
- **Chemicals:** R848 (MESH:C402365)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11973730/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11973730/full.md

## References

44 references — full list in the complete paper: https://tomesphere.com/paper/PMC11973730/full.md

---
Source: https://tomesphere.com/paper/PMC11973730